Episode Details
Back to Episodes
FDA Approves Moderna’s mRNA Flu Shot for Seniors | Raleigh News
Description
FDA just approved Moderna’s new mRNA flu vaccine, mFLUSIVA, for adults over 50 — set to roll out in the 2026-2027 season. After initially rejecting the application, regulators reversed course after Moderna agreed to conduct a real-world study. This mRNA tech could revolutionize flu response by speeding up production and adapting faster to new strains. Moderna will compare it to the current high-dose shot for seniors, with data expected this winter. For everyone 6 months and older, getting vaccinated by October remains key to preventing serious illness and saving lives.
Listen in comfort:
Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn.
Advertise on DNN:
advertise@thednn.ai
This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.
View sources & latest updates:
https://sources.thednn.ai/5dde67be6c723aca